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Myocardial Infarc.on

O"erbein University, Westerville, Ohio
Sarah Robinson, BSN, RN, CCRN

•

•

•

Cardiovascular disease is a term
used to refer to pathologies
aﬀec5ng the structure and func5on
of the heart and blood vessels
(Stewart, Manmathan, & Wilkinson,
2017). The most common type of
cardiovascular disease is coronary
artery disease (Center for Disease
Control and Preven5on [CDC],
2017).
A serious complica5on of coronary
artery disease (CAD) is myocardial
infarc5on (MI), commonly known as
a heart aNack (CDC, 2017). It is
es5mated that in the United States
every 40 seconds a person suﬀers
from a myocardial infarc5on,
resul5ng in approximately 790,000
myocardial infarc5ons every year
(CDC, 2017).
Coronary artery disease is primarily
considered a preventable condi5on
(Stewart, Manmathan, & Wilkinson,
2017). As an intensive care unit
nurse, and future APRN it is
impera5ve to understand CAD and
the associated risk factors to
eﬀec5vely care for and educate
pa5ents. Pa5ent educa5on is
pivotal in reducing the incidence of
myocardial infarc5on in the United
States through risk factor
modiﬁca5on.

•

•

•

•

•

Case Study
•

A 57-year-old man presents to the
emergency room with complaints
of chest pain and shortness of
breath that started 30 minutes ago.
The pa5ent is pale and diaphore5c,
and is now complaining of nausea.
A health history reveals the pa5ent
has type 2 diabetes mellitus,
hypertension, and dyslipidemia. An
electrocardiogram (ECG) is
completed, which shows ST
segment eleva5on in leads II, III,
and aVF. A hospital wide STEMI
alert is ini5ated, no5fying the
interven5onal cardiologist and
cardiac cath lab. The emergency
room staﬀ begins prepping the
pa5ent for emergent percutaneous
coronary interven5on (PCI).

Signiﬁcance of
Pathophysiology

Underlying
Pathophysiology

Introduc.on

•

The heart receives oxygenated
blood from the aorta via the
coronary arteries. Myocytes also
known as muscle cells, require a
con5nuous supply of oxygenated
blood for proper func5oning.
(Davies, 2016).
Atherosclerosis is a process
through which lipid-laden
macrophages accumulate within
the arterial wall to form a lesion
called a plaque, resul5ng in
thickening and hardening of the
vessel (McCance & Huether, 2018).
Coronary artery disease is a
narrowing of the coronary arteries,
most commonly caused by
atherosclerosis (Andrus et al.,
2015).
Myocardial ischemia occurs when
the coronary arteries are unable to
deliver enough oxygen and
nutrients to meet the demand of
the myocardium (McCance &
Huether, 2018).
When ischemia to the myocardium
is prolonged, myocardial infarc5on
occurs resul5ng in irreversible
damage and necrosis of the
myocardium. Damage to the
myocardium can result in abnormal
electrical impulses, decreased
contrac5lity, and impaired ejec5on
of blood into the pulmonary and/or
systemic circula5on (Davies, 2016).
Myocardial infarc5on can be
classiﬁed clinically as a non-STeleva5on MI (NSTEMI) or STeleva5on MI (STEMI). Both
classiﬁca5ons have speciﬁc
treatment guidelines that include
an5thrombo5c therapy and PCI.
Percutaneous coronary
interven5on includes angioplasty,
stent placement, and
thrombectomy.
•

•

NSTEMI: plaque
rupture/erosion with
non-occlusive
thrombosis
STEMI: plaque
rupture/erosion with
occlusive thrombosis
(Thygesen et al., 2018)

•

•

•

•

Myocardial infarc5on is a 5me
sensi5ve condi5on that requires
interven5on to restore coronary
blood ﬂow. The aﬀected
myocardium becomes cyano5c
within 8 to seconds of decreased
blood ﬂow. ECG changes become
visible within 30 to 60 seconds of
hypoxia. Aaer approximately 20
minutes of ischemia, cellular death
occurs (McCance & Huether,
2018).
The amount of damage to the
myocardium depends on the
loca5on of the infarct and length of
5me before reperfusion (Davies,
2016).
Poten5al complica5ons of
myocardial infarc5on include
cardiogenic shock, heart failure,
mitral valve regurgita5on,
ventricular septal rupture,
dysrhythmias, pericardi5s, and
sudden death (O’Gara et al., 2013).
Understanding the
pathophysiology of myocardial
infarc5on provides nurses and
healthcare providers with the
knowledge required to educate
pa5ents on how to recognize signs
and symptoms of a MI, and how a
MI can be prevented.

Diagnosis

Signs & Symptoms
•

Chest pain or discomfort
•

•

•
•
•
•
•
•
•
•
•
•

Pain characteris5cs vary
among pa5ents, and is
frequently described as
crushing, substernal
pressure, or squeezing.
Radia5on to the arm,
shoulder, neck, or jaw is
common, oaen to the lea
side.

Dyspnea
Fa5gue
Lightheadedness
Pallor
Diaphoresis
Palpita5ons
Nausea with possible vomi5ng
Low grade pyrexia
Hypotension or hypertension
Atypical symptoms are oaen
present in older people, women,
and individuals with diabetes (Peate
& Jones, 2014; McCance & Huether,
2018).

According to the Fourth Universal Deﬁni5on
of Myocardial Infarc5on, a diagnosis of
myocardial infarc5on is appropriate when
there is acute myocardial injury detected by a
rise and/or fall of cardiac troponin (cTn)
values with at least 1 value above the 99th
percen5le upper reference limit (URL), and
clinical evidence of acute myocardial ischemia
as evidenced by at least one of the following
(Thygesen et al., 2018):
•
•

•
•

•

Symptoms of myocardial ischemia
Electrocardiographic changes indica5ng
new or presumed new ischemia (STsegment changes, T-wave changes or
lea bundle branch block)
Development of pathological Q waves
on electrocardiogram
Imaging evidence of viable myocardium
loss or new regional wall mo5on
abnormality
Coronary thrombus iden5ﬁed by
angiography or autopsy
(Thygesen et al., 2018)

•

Implica.ons for
Nursing Care

•
•
•
•

•

Diabetes mellitus
Dyslipidemia
Hypertension
Overweight and obesity
Unhealthy diet and sedentary
lifestyle
•
Smoking
(Peate & Jones, 2014)

•
•

Non-modiﬁable
Risk Factors
Figure 1. Development of atherosclerosis. (Mayo Clinic, 2019)

Conclusions
Myocardial infarc5on is a life
threatening condi5on that requires
early interven5on. If coronary blood
ﬂow is not quickly restored,
myocardial ischemia will progress to
cell death and necrosis (Thygesen et
al., 2018). Healthcare providers must
be able to recognize the signs and
symptoms of a myocardial infarc5on
so early reperfusion therapy can be
ini5ated to reduce morbidity and
mortality.

.

•

•
•
•
•
•

NSTEMI: administra5on of
an5platelet and an5coagulant,
possible PCI (McCance & Huether,
2018)
STEMI: early reperfusion therapy
with administra5on of an5platelet
and an5coagulant, and PCI. If PCI is
unavailable administra5on of a
ﬁbrinoly5c (O’Gara et al., 2013)

•

•

Modiﬁable Risk
Factors

•
Advanced age
•
Male gender
•
Family history
•
Race
(Peate & Jones, 2014)

Treatment

Recognize signs and symptoms of
myocardial ischemia and infarc5on
Con5nuous monitoring for new ECG
changes
Frequent monitoring of BP, HR,
respira5on rate, and SpO2
Cardiac assessment for abnormal
heart sounds (S3, S4), strength of
pulses, presence of jugular venous
disten5on, skin color and
temperature (Peate & Jones, 2014)
Pulmonary assessment for breath
sounds, presence of crackles,
respiratory eﬀort, and shortness of
breath (Peate & Jones, 2014)
Administra5on of medica5ons,
which could include an5platelet
therapy, an5coagulants, nitrates,
diure5cs, inotropes, and analgesics
(Rollini & Angiolillo, 2015; Peaste &
Jones, 2014).
Monitor PCI access site for
complica5ons such as bleeding,
hematoma, pseudoaneurysm, or
retroperitoneal bleeding (O’Gara et
al., 2013). Complica5ons should be
immediately reported to the
healthcare provider.
Manage hemostasis device or
arterial sheath as indicated.
Pa5ent educa5on is essen5al for a
pa5ent who has been diagnosed
with a myocardial infarc5on.
Educa5on should focus on how to
take medica5ons including why
they were prescribed, diet
modiﬁca5on, exercise, smoking
cessa5on, and management of
other risk factors. The pa5ent
should also be educated on cardiac
rehabilita5on programs and when
to follow up with a physician
(Aroesty & Kannam, 2018).

Figure 2. Myocardial infarction
due to an occlusive thrombus
(Mayo Clinic, 2018).
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